According to Theravance Biopharma 's latest financial reports the company's current revenue (TTM) is A$93.01 M. In 2023 the company made a revenue of A$84.28 M an increase over the revenue in the year 2022 that were of A$75.45 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.